Stocks and Investing Stocks and Investing
Thu, November 2, 2023
[ 12:00 AM ] - WOPRAI
Brian Ossenbeck Maintained (WERN) at Hold with Decreased Target to $37 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Brent Bracelin Reiterated (WEAV) at Hold and Held Target at $8 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Ivan Feinseth Maintained (VZ) at Strong Buy with Decreased Target to $45 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Seth Basham Maintained (W) at Buy with Decreased Target to $65 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Nicholas Zangler Maintained (W) at Buy with Decreased Target to $75 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (W) at Hold with Decreased Target to $60 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Peter Keith Maintained (W) at Buy with Decreased Target to $73 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Joshua Long Reiterated (WING) at Buy and Held Target at $240 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Jeffrey Bernstein Maintained (WING) at Buy with Increased Target to $225 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Andrew Charles Maintained (WING) at Buy with Increased Target to $235 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Carril Maintained (WING) at Hold with Increased Target to $205 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Brian Harbour Maintained (WING) at Hold with Increased Target to $199 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Kevin Fischbeck Downgraded (ALHC) to Hold and Held Target at $7.25 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Daniel Ives Maintained (ALIT) at Buy with Decreased Target to $11 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Stanley Elliott Maintained (AGCO) at Strong Buy with Decreased Target to $160 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Mayank Tandon Maintained (ALKT) at Strong Buy with Increased Target to $24 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Alexei Gogolev Maintained (ALKT) at Buy with Increased Target to $21 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Colin Bristow Maintained (AMGN) at Hold with Decreased Target to $268 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Robyn Karnauskas Upgraded (AMGN) to Strong Buy and Held Target at $320 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Gregory Renza Maintained (AMGN) at Hold with Increased Target to $256 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Timothy Arcuri Maintained (AMD) at Strong Buy with Decreased Target to $135 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Graig Suvannavejh Initiated (ADVM) at Strong Buy and Held Target at $20 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Jimmy Bhullar Maintained (AFL) at Hold with Increased Target to $80 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Atif Malik Maintained (AEIS) at Strong Buy with Decreased Target to $107 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Brandt Montour Maintained (BALY) at Hold with Decreased Target to $10 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Mike Matson Maintained (ATRC) at Strong Buy with Decreased Target to $49 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Robbie Marcus Maintained (ATRC) at Buy with Decreased Target to $50 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Craig Hettenbach Maintained (AMWL) at Hold with Decreased Target to $35 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Johnen Initiated (AMZN) at Strong Buy and Held Target at $160 on, Nov 2nd, 2023
[ 12:00 AM ] - WOPRAI
Eliana Merle Maintained (ANAB) at Hold with Decreased Target to $21 on, Nov 2nd, 2023

Eliana Merle Maintained (ANAB) at Hold with Decreased Target to $21 on, Nov 2nd, 2023


Published on 2024-10-28 07:16:07 - WOPRAI, Eliana Merle
  Print publication without navigation


Eliana Merle of UBS, Maintained "AnaptysBio, Inc." (ANAB) at Hold with Decreased Target from $28 to $21 on, Nov 2nd, 2023.

Eliana has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, all agrees with Eliana's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • David Nierengarten of "Wedbush" Maintained at Hold with Decreased Target to $26 on, Tuesday, August 8th, 2023
Contributing Sources